EHGOF withdraws its claims

RNS Number : 7238V
Iconic Labs PLC
16 April 2021
 

16 April 2021

Iconic Labs Plc ("Iconic Labs" or the "Company")

 

European High Growth Opportunities Securitization Fund ("EHGOF") withdraws its claims

 

Iconic Labs Plc (LSE:ICON), a multidivisional new media and technology business announces that following the settlement agreement with EHGOF and various conditions having been fulfilled (including the termination of the employment and/or offices held (as applicable) of Sarah Dees and Stephen Birrell, the termination of the consultancy agreement with James Parsons, and the appointment of Brad Taylor as chief executive officer of the Company) an order has been applied for staying the proceedings against the Company.

 

The Company is also pleased to confirm that EHGOF has indicated its willingness to enter into discussions regarding a finance facility of up to £50 million to support the Company's growth plans.

 

Brad Taylor, CEO, Iconic Labs said, "We are excited about our ambitious acquisition and growth plans and look forward to discussing these plans further with EHGOF." 

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information for the purposes of the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

**ENDS**

For further information, please visit the Company's website  www.iconiclabs.co.uk  or contact:

Iconic Labs  ir@iconiclabs.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRUNRWRAUUSARR

Companies

Iconic Labs (ICON)
UK 100